Direxion Daily S&P Biotech Bull 3X Shares
This fund multiplies its index's move each day and resets that multiple daily. Because daily returns compound, its long-run return can differ from the headline multiple.
$251.04−37.96 (−13.13%)
- Expense ratio
- 0.96%
- Fund size
- $576M
- 1Y return
- +237.2%
- Yield · Last 12 months
- 0.35%
- Holdings
- 156
- Volume · 30D
- 0.5M sh
- NAV per share
- $270.91
- 52W range
The ETF.net LABU Grade
Score 64 of 100 sits in the B band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.AScore 73Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.CScore 51Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.BScore 63Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.Not scoredDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.BScore 59Category rank
Our read on LABU
BThree times the daily move of an index of roughly 160 biotech stocks, the corner of the market where one trial readout resets the tape. Direxion's 2015-vintage bull leg, with a bear twin wired to the same benchmark.
The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the S&P Biotechnology Select Industry Index.
Why people hold it
- Fee is 0.96%, under the typical 3x fund's. Leverage is the pricey shelf in ETF land, and this one sits on the cheaper side of it.
- The 3x rides a basket of roughly 160 biotech names, not one drug story, so no single approval or rejection owns the day.direxion.com
- Trading since 2015 and actively traded, and it stands in the upper tier of the leveraged bull funds we cover.
- A bear twin runs -300% of the same index daily, so the other side of the biotech view uses identical plumbing.direxion.com
Worth knowing
- The 300% target resets every day. Hold past that and compounding takes the wheel, so multi-day results can land far from 3x the index move over the same stretch.direxion.com
- Leverage is pointed at one volatile industry, so daily swings arrive tripled in both directions. Position sizing does a lot of work here.
- Distributions land annually or semiannually at most. This is built as a trading tool, not an income stream.
LABU Holdings
- Other
- 156
- 77%
- SPSIBI SWAP ASSET LEG (SPSIBIUBL)
Sectors
- Health Care99.3%
- Financials0.7%
Geography
- United States95.43%
- United Kingdom1.35%
- Switzerland1.11%
- Ireland1.08%
- Netherlands1.03%
LABU Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
LABU$33,718
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | LABU |
|---|---|
| Year to date | +81.3% |
| 1 month | −8.9% |
| 3 months | +25.6% |
| 1 year | +237.2% |
| 3 years | +56.9% |
| 5 years | −25.1% |
| 10 years | −12.3% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | LABU |
|---|---|---|
| 2026 YTD | +81.3% | |
| 2025 | +79.2% | |
| 2024 | −26.0% | |
| 2023 | −13.4% | |
| 2022 | −80.4% | |
| 2021 | −64.2% | |
| 2020 | +74.7% |
LABU in the news
LABU Dividends
- 0.35%
- $1.01
- $0.91 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Dec 23, 2025 | Dec 31, 2025 | $0.91 |
| Sep 23, 2025 | Sep 30, 2025 | $0.10 |
| Jun 24, 2025 | Jul 1, 2025 | $0.22 |
| Mar 25, 2025 | Apr 1, 2025 | $0.11 |
| Jun 25, 2024 | Jul 2, 2024 | $0.15 |
| Mar 19, 2024 | Mar 26, 2024 | $0.16 |
| Dec 21, 2023 | Dec 29, 2023 | $0.21 |
| Sep 19, 2023 | Sep 26, 2023 | $0.04 |
| Jun 21, 2023 | Jun 28, 2023 | $0.18 |
| Dec 23, 2019 | Dec 31, 2019 | $0.11 |
| Sep 24, 2019 | Oct 1, 2019 | $0.22 |
| Jun 25, 2019 | Jul 2, 2019 | $0.74 |
LABU Risk
This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.
- 80.2%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.78
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −97.1%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 3.12
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
LABU Cost
0.96%
LABU0.96%
- The middle half of 3x Leveraged Long funds
- Median 0.98%
6 of the 30 3x Leveraged Long funds charge less.